The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Mektix 12.5 mg/125 mg chewable tablets for dogs weighing at least 5 kg

Krka, d.d., Novo mestoVPA10774/061/002

Main Information

Trade NameMektix 12.5 mg/125 mg chewable tablets for dogs weighing at least 5 kg
Active SubstancesMilbemycin oxime
Dosage FormChewable tablet
Licence HolderKrka, d.d., Novo mesto
License Holder AddressŠmarješka cesta 6
8501 Novo mesto
Licence NumberVPA10774/061/002

Group Information

ATC CodeQP54AB51 milbemycin oxime, combinations
Therapeutic ClassEndectoparasiticides


License statusAuthorised
Licence Issued27/07/2018
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back